CBD 뉴트라슈티컬 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global CBD Nutraceuticals Market generated USD 10.7 billion in 2024 and is expected to grow at a remarkable CAGR of 17.5% from 2025 to 2034. This impressive growth is primarily driven by the increasing awareness of the health benefits of cannabidiol (CBD) in managing chronic conditions and promoting overall wellness. As more consumers shift their focus toward plant-based, clean-label, and health-enhancing products, the demand for CBD nutraceuticals continues to gain momentum. Consumers are seeking natural alternatives to traditional medications, leading to a surge in interest in CBD-based supplements that offer anti-inflammatory, analgesic, and stress-relief properties without the risk of addiction. Furthermore, advancements in personalization tools powered by artificial intelligence (AI) have significantly enhanced customer experiences by guiding product choices and offering tailored recommendations.

Alongside this, the industry is witnessing a major transition toward sustainable, organic CBD farming practices, resulting in more efficient and cost-effective extraction methods that are benefiting both new and established players. The rising inclination toward eco-friendly production methods is creating opportunities for brands to cater to environmentally conscious consumers while maintaining high-quality standards. Additionally, favorable regulatory frameworks, particularly in key markets such as the United States, are encouraging further investments and driving innovation in the CBD nutraceuticals space.

The market is segmented into several product categories, including CBD oils, tinctures, capsules, soft gels, gummies, and other forms. CBD oils have emerged as the most popular segment, generating USD 3 billion in 2023. These oils, known for their high absorption rate and ease of use, provide effective relief from chronic pain, stress, and anxiety. Administered sublingually, CBD oils act quickly and efficiently, making them a preferred choice for individuals seeking fast-acting and long-lasting effects. Available in various concentrations, these oils cater to a wide range of consumer preferences and therapeutic needs, making them one of the most versatile products in the market.

The application of CBD nutraceuticals spans across pain management, sleep disorders, mental health, stress reduction, and other health concerns. The pain management segment dominated the market with a significant share of 35.5% in 2024, driven by the increasing prevalence of chronic pain conditions such as arthritis, fibromyalgia, and migraines. CBD's proven anti-inflammatory and analgesic properties have positioned it as a safer and more effective alternative to traditional pain medications, which often come with undesirable side effects. Both healthcare providers and patients are increasingly opting for CBD due to its non-addictive nature and ability to provide sustained relief.

The U.S. CBD nutraceuticals market is projected to generate USD 25.7 billion by 2034, maintaining a robust CAGR of 17.5% from 2025 to 2034. As the largest market for CBD nutraceuticals globally, the U.S. benefits from favorable regulations, high consumer awareness, and increasing acceptance of cannabis-derived products. The growing incidence of chronic conditions, including arthritis, anxiety, and sleep disorders, has further fueled the demand for CBD-based nutraceuticals in the region. The evolving regulatory landscape and ongoing research into the therapeutic potential of CBD are expected to drive sustained growth, positioning the U.S. market at the forefront of the global CBD nutraceuticals industry.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of chronic diseases and mental health disorders
    • 3.2.1.2 Growing demand for plant-based and natural supplements
    • 3.2.1.3 Innovations in product development and formulations
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High costs of CBD extraction and product development
    • 3.2.2.2 Limited consumer education and misconceptions about CBD
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Future market trends
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021-2034 ($ Mn)

• 5.1 Key trends
• 5.2 CBD oils
• 5.3 CBD tinctures
• 5.4 CBD capsules and softgels
• 5.5 CBD gummies and chews
• 5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Application, 2021-2034 ($ Mn)

• 6.1 Key trends
• 6.2 Pain management
• 6.3 Anxiety and stress reduction
• 6.4 Sleep disorders
• 6.5 Mental health
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021-2034 ($ Mn)

• 7.1 Key trends
• 7.2 Retail stores
• 7.3 Pharmacies
• 7.4 E-commerce
• 7.5 Other distribution channels

Chapter 8 Market Estimates and Forecast, By Region, 2021-2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Bluebird Botanicals
• 9.2 Charlotte's Web
• 9.3 CV Sciences
• 9.4 Diamond CBD
• 9.5 Elixinol
• 9.6 ENDOCA
• 9.7 Foria Wellness
• 9.8 Garden of Life (Nestle)
• 9.9 Green Roads
• 9.10 Irwin Naturals
• 9.11 Isodiol
• 9.12 Medical Marijuana
• 9.13 MEDTERRA